Table 6.
Subgroup analysis.
| Variables | Categories/range | Pain intensity* | Depressive symptoms | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stable severe and moderate vs other trajectories (n = 67) | U-shape vs other trajectories | Inverted U-Shape vs other trajectories | Severe slightly improving or stable moderate trajectories vs other trajectories | Stable mild vs other trajectories | Stable very mild or none vs other trajectories | ||||||||
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | ||
| Cortisol variable | |||||||||||||
| Percentage of change in cortisol, pg/mg | −60.5 to 250 | 1.0 (1.0, 1.0) | 0.547 | 1.0 (1.0, 1.0) | 0.630 | 1.0 (1.0, 1.0) | 0.690 | 1.0 (1.0, 1.0) | 0.722 | 1.0 (1.0, 1.0) | 0.753 | 1.0 (1.0, 1.0) | 0.413 |
| Pre–COVID-19 variables | |||||||||||||
| Pain intensity before COVID-19 | Score from 0 = No pain to 10 = worst imaginable pain) | 1.3 (0.8, 2.2) | 0.269 | 1.4 (0.7, 2.7) | 0.389 | 0.7 (0.5, 1.2) | 0.202 | 0.8 (0.3, 1.9) | 0.612 | 0.9 (0.5, 1.4) | 0.571 | 1.5 (0.8, 2.9) | 0.248 |
| Depressive symptoms before COVID-19 | T score from 41.0 to 79.4 | 1.0 (0.9, 1.1) | 0.996 | 1.0 (0.9, 1.2) | 0.553 | 1.0 (0.9, 1.1) | 0.819 | 1.3 (1.0, 1.5) | 0.036 | 1.1 (1.0, 1.2) | 0.210 | 0.9 (0.8, 1.0) | 0.035 |
| Pain interference before COVID-19 | T score from 41.6 to 75.6 | 1.0 (0.8, 1.1) | 0.597 | 0.9 (0.7, 1.1) | 0.244 | 1.0 (0.9, 1.2) | 0.841 | 1.1 (0.8, 1.6) | 0.448 | 1.0 (0.8, 1.2) | 0.788 | 0.9 (0.8, 1.2) | 0.612 |
| Physical function before COVID-19 | T score from 22.9 to 56.9 | 0.7 (0.5, 0.9) | 0.007 | 1.1 (0.9, 1.4) | 0.262 | 1.0 (0.8, 1.2) | 0.961 | 1.1 (0.8, 1.5) | 0.556 | 1.0 (0.8, 1.2) | 0.716 | 1.1 (0.9, 1.4) | 0.441 |
| Onset-of-pandemic variables | |||||||||||||
| Age in years | Years | 1.0 (0.9, 1.1) | 0.730 | 1.0 (0.9, 1.1) | 0.919 | 1.0 (1.0, 1.1) | 0.584 | 1.0 (0.9, 1.1) | 0.613 | 1.0 (0.9, 1.0) | 0.544 | 1.1 (0.9, 1.1) | 0.728 |
| Acute stress disorder | Score from 0 to 76 | 1.1 (1.0, 1.2) | 0.098 | 0.9 (0.8, 1.0) | 0.192 | 1.0 (0.9, 1.1) | 0.930 | 1.1 (1.0, 1.3) | 0.098 | 1.0 (1.0, 1.1) | 0.337 | 0.8 (0.7, 0.9) | 0.004 |
| Finding the COVID-19 pandemic stressful | Score from 0 (not at all) to 10 (extremely) | 1.2 (0.9, 1.6) | 0.262 | 1.2 (0.8, 1.9) | 0.328 | 0.7 (0.5, 1.0) | 0.038 | 1.7 (0.9, 3.3) | 0.131 | 0.8 (0.6, 1.2) | 0.313 | 1.2 (0.7, 1.9) | 0.537 |
| Finding lockdown measures associated with the COVID-19 pandemic stressful | Score from 0 (not at all) to 10 (extremely) | 1.0 (0.8, 1.4) | 0.677 | 0.9 (0.6, 1.3) | 0.513 | 1.0 (0.8, 1.4) | 0.783 | 1.2 (0.7, 2.0) | 0.529 | 1.1 (0.8, 1.5) | 0.403 | 0.8 (0.6, 1.3) | 0.393 |
| Methodological variable | |||||||||||||
| Months between pre–COVID-19 and baseline surveys | 0–17 mo | 1.0 (0.8, 1.2) | 0.753 | 1.0 (0.8, 1.2) | 0.716 | 1.1 (0.9, 1.2) | 0.434 | 0.9 (0.8, 1.1) | 0.347 | 1.1 (0.9, 1.2) | 0.428 | 1.0 (0.8, 1.2) | 0.809 |
| Model evaluation | |||||||||||||
| Hosmer and Lemeshow test | 0.954 | 0.533 | 0.789 | 0.268 | 0.032 | 0.339 | |||||||
Association between cortisol and pain intensity trajectories and depressive symptoms adjusted for several variables.
Stable mild pain (n = 5) vs other trajectories (n = 62) were not included because of small sample size.